LONDON, Oct 27, 2023 – (ACN Newswire) – EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family has transferred its 70% stake in the Boiron Group to Boiron Developpement, together with the Boiron employee fund for c. 5% of the capital.
Boiron is a French pharmaceutical company focused on natural medicine, founded in 1932 by pharmacists Jean and Henri Boiron. The company is built around homeopathy and has spearheaded the industry’s global development.
Boiron today is the global market leader in homeopathy and a leading global player in natural medicines, with 2022 revenues of €534M. The company offers a diversified portfolio of natural, innovative, science-based, and personalized pharmaceutical products. Over 50% of Boiron’s sales are realized outside of France. Boiron benefits from an integrated value chain from registration to distribution, including in-house manufacturing, with the company currently present in 50 countries globally through 23 subsidiaries and 30 distributors. Boiron has also established a strong footprint in the U.S. with €120M in U.S. revenue, with a large portion of products sold through the e-commerce channel.
EW Healthcare Partners is excited to partner with the Boiron family to help further accelerate the company’s growth, by expanding the company’s offering into additional healthcare verticals and capitalising on the existing platform to launch additional products, in particular in the U.S.
About EW Healthcare Partners (“EW”)
With over $2 billion of capital raised since 2014, EW Healthcare Partners seeks to make growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. EW Healthcare Partners has a singular commitment to the healthcare industry and has been a long-term investor in numerous healthcare companies, ranging across sectors, stages and geographies. The team of senior investment professionals, operating partners and advisors is based in New York, London and Houston. https://www.ewhealthcare.com
Anne DeMaret, Investor Relations, [email protected] (281) 528-1956
Topic: Press release summary
Source: EW Healthcare Partners
Sectors: BioTech, Healthcare & Pharm
From the Asia Corporate News Network
Copyright © 2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Source : ACN Newswire
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine- https://www.afric.info https://artfine.net https://cleaninghome.net https://www.7a7.biz https://deguise-moi.com https://100-chaussures.com https://www.mondialnews.com https://www.lejardin-adlibitum.net -/- Save the date – 26e Congrès ANDES Logbuch-Verlag 25 sac en papier kraft autocollant père Noël Saint Nicolas emballage 14 x 22 x 5,6 cm Attentat à Bruxelles: la police lance un appel à témoins Markoff Regulation Celebrates Breast Most cancers Consciousness Month With … – insideARM.com Voitures électriques à 1200 km d’autonomie, énorme fuite Xbox et révolution chez Intel – L’actu tech de la semaine -*- Vislone Abri de Stockage en Bois Pin Imprégné de Durable pour Jardin 150 x 100 x 210 cm The 10 Best Black Friday AirPods Deals: Up to $99 Off Max, Pro and More – CNET My Favorite Mini Massage Gun Is $50 Off Right Now – CNET Sport | Retired Springbok centre De Jongh moves into Stormers coaching structures NiteIze Sidelock 4 Mousqueton Double Noir Munich G3 Profit – Tennis jaune/bleu à semelle lisse O’FRESH Brumisateur Personnel à mémoire de Forme Cobra Opinel Inox Couteau Fermant, Adulte Bubinga Boîte EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine *EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicinenews7.asia EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine